Recommended

New webinar with Fujifilm: Monocyte activation test (MAT): Insight into examining regulations and markets prospects
New webinar: The path to optimisation in pharmaceutical microbiology
Join our webinar: An alternative medium to support sterility testing using the Growth Direct® Rapid Sterility System
Discover more in our new application note: validating recombinant cascade reagents in 3 simple steps
Whitepaper

Whitepaper: Bridging the cell and gene therapy gap

The current understanding among sponsors of the workflow from cell collection, to manufacturing, and to the clinical site for patient administration.

With the rise of the development of cell and gene therapies (CGT) and their associated clinical trials, it is becoming increasingly important to bridge the knowledge and service gaps from manufacturing these advanced therapies to the end-to-end supply chain management. A survey was conducted by Catalent and Fierce Biotech to better understand current perceptions of these gaps by individuals in the CGT industry, including specialized supply chain needs associated with these types of studies.